Sugi Predict

Sugi Predict / Compounds / SCHEMBL163889

SCHEMBL163889

SCHEMBL163889

Oc1cnc2ccc(Br)cc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.54
▸ CDK8 P49336 1/20 0.54
▸ CLK2 P49760 1/20 0.54
▸ CDK7 P50613 1/20 0.54
▸ CDK9 P50750 1/20 0.54
▸ CDK5 Q00535 1/20 0.54
▸ ACVR1 Q04771 1/20 0.54
▸ ROCK1 Q13464 1/20 0.54
▸ DYRK1A Q13627 1/20 0.54
▸ LRRK2 Q5S007 1/20 0.54
▸ CLK4 Q9HAZ1 1/20 0.54
▸ DYRK1B Q9Y463 1/20 0.54
▸ BACE1 P56817 1/20 0.41
▸ MALT1 Q9UDY8 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ BIRC5 O15392 1/20 0.39
▸ ALK Q9UM73 1/20 0.38
▸ HTT P42858 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4534377 0.84 CYP1A2 (0.50) MAP4K4CDK8CLK2CDK7CDK9
SCHEMBL534471 0.84 DYRK1A (0.46) MAP4K4CDK8CLK2CDK7CDK9
SCHEMBL20528292 0.83 BACE1 (0.47) DYRK1ABACE1MALT1MEN1KMT2A
SCHEMBL2000504 0.76 MAP4K4 (0.54) MAP4K4CDK8CLK2CDK7CDK9
SCHEMBL21988901 0.76 MAP4K4 (0.54) MAP4K4CDK8CLK2CDK7CDK9
SCHEMBL2224981 0.76 MAP4K4 (0.54) MAP4K4CDK8CLK2CDK7CDK9
SCHEMBL164336 0.76 DYRK1A (0.54) MAP4K4CDK8CLK2CDK7CDK9
SCHEMBL359616 0.76 BACE1 (0.41) BACE1MALT1MEN1KMT2ABIRC5
SCHEMBL358365 0.76 ALDH1A1 (0.52) BACE1MALT1MEN1KMT2ABIRC5
SCHEMBL5048586 0.76 CYP1A2 (0.57) BACE1MALT1BIRC5HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626870-A1 NONCOVALENT KEAP1-NRF2 SMALL-MOLECULE INHIBITORS University of Copenhagen (DK) 2025-10-08 — — EP disclosed
US-12103921-B2 Chemical compounds PFIZER INC. (US) 2024-10-01 — — US disclosed
CN-118525020-A Compound with CLK and DYRK inhibiting activity, preparation method and application thereof 赛诺哈勃药业（成都）有限公司 2024-08-20 — — CN disclosed
WO-2024115641-A1 NONCOVALENT KEAP1-NRF2 SMALL-MOLECULE INHIBITORS UNIVERSITY OF COPENHAGEN (DK) 2024-06-06 — — WO disclosed
WO-2024115641-A1 NONCOVALENT KEAP1-NRF2 SMALL-MOLECULE INHIBITORS UNIVERSITY OF COPENHAGEN (DK) 2024-06-06 — — WO disclosed
US-20230382892-A1 Chemical Compounds PFIZER INC. (US) 2023-11-30 — — US disclosed
US-11702405-B2 Chemical compounds PFIZER INC. (US) 2023-07-18 — — US disclosed
WO-2023103898-A1 COMPOUND HAVING CLK AND DYRK INHIBITORY ACTIVITIES, PREPARATION METHOD THEREFOR AND USE THEREOF 赛诺哈勃药业（成都）有限公司 2023-06-15 — — WO disclosed
WO-2023103898-A1 COMPOUND HAVING CLK AND DYRK INHIBITORY ACTIVITIES, PREPARATION METHOD THEREFOR AND USE THEREOF 赛诺哈勃药业（成都）有限公司 2023-06-15 — — WO disclosed
US-20220348555-A1 Chemical Compounds PFIZER INC. (US) 2022-11-03 — — US disclosed
WO-2011087837-A9 FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-09-09 — — WO disclosed
WO-2011087837-A2 FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-21 — — WO disclosed
US-20110092504-A1 INHIBITORS OF PI3 KINASE AMGEN INC. 2011-04-21 — — US disclosed
EP-2307400-A2 INHIBITORS OF PI3 KINASE Amgen, Inc (US) 2011-04-13 — — EP disclosed
WO-2009155121-A2 INHIBITORS OF PI3 KINASE AMGEN INC. (US) 2009-12-23 — — WO disclosed
US-6831175-B2 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine ABBOTT LABORATORIES 2004-12-14 — — US disclosed
EP-1463505-A2 3-(PHENYL-ALKOXY)-5-(PHENYL)-PYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER Abbott Laboratories (US) 2004-10-06 — — EP disclosed
US-20030199511-A1 Kinase inhibitors ABBVIE INC. 2003-10-23 — — US disclosed
US-20030187026-A1 Kinase inhibitors ABBOTT LABORATORIES 2003-10-02 — — US disclosed
WO-2003051366-A2 3-(PHENYL-ALKOXY)-5-(PHENYL)-PYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER ABBOTT LABORATORIES (US) 2003-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702405-B2 Chemical compounds HBZ, HBB, HBS1L MAP4K4 2339/4885CDK8 1496/4885CLK2 2908/4885
US-20030187026-A1 Kinase inhibitors MAP3K20, MAP3K19, MAP3K1 MAP4K4 26/4885CDK8 132/4885CLK2 260/4885
US-20230382892-A1 Chemical Compounds HBZ, HBB, HBS1L MAP4K4 2339/4885CDK8 1496/4885CLK2 2908/4885
US-20030199511-A1 Kinase inhibitors MAP3K20, MAP3K19, MAP3K1 MAP4K4 26/4885CDK8 132/4885CLK2 260/4885
US-12103921-B2 Chemical compounds HBZ, HBB, HBS1L MAP4K4 2339/4885CDK8 1496/4885CLK2 2908/4885
US-20220348555-A1 Chemical Compounds HBZ, HBB, HBS1L MAP4K4 2339/4885CDK8 1496/4885CLK2 2908/4885
US-20110092504-A1 INHIBITORS OF PI3 KINASE PIK3CA, PIK3R1, PIK3R5 MAP4K4 239/4885CDK8 570/4885CLK2 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.